Fink K, Al-Mondhiry H
Cancer. 1976 Apr;37(4):1999-2004. doi: 10.1002/1097-0142(197604)37:4<1999::aid-cncr2820370451>3.0.co;2-u.
Five patients with idiopathic thrombocytopenic purpura (ITP) associated with malignant lymphoma are presented, and twelve other cases reported in the literature are reviewed. Thirteen patients (76%) had Hodgkin's disease; two had diffuse histiocytic, one, diffuse mixed lymphoma. Idiopathic thrombocytopenic purpura presented as the sole clinical manifestation of initial or recurrent lymphoma in 10 of 15 cases (67%). The spleen was not palpable even in patients who showed involvement with lymphoma at splenectomy. Three patients were asplenic at the onset of idiopathic thrombocytopenic purpura. Successful therapy of the thrombocytopenia correlated with effective control of the underlying lymphoma. Splenectomy gave favorable results in 9 of 10 cases (90%) and uncovered occult lymphoma in five patients. Chemotherapeutic drugs were successful in seven of 12 trials (58%) and only when the underlying disease was also controlled. The overall prognosis was related to the status of the lymphoma and was not altered by the occurrence of the idiopathic thrombocytopenic purpura.
本文报告了5例与恶性淋巴瘤相关的特发性血小板减少性紫癜(ITP)患者,并对文献中报道的其他12例病例进行了回顾。13例患者(76%)患有霍奇金病;2例患有弥漫性组织细胞淋巴瘤,1例患有弥漫性混合淋巴瘤。在15例病例中的10例(67%)中,特发性血小板减少性紫癜表现为初始或复发性淋巴瘤的唯一临床表现。即使在脾切除术中显示有淋巴瘤累及的患者中,脾脏也触诊不到。3例患者在特发性血小板减少性紫癜发病时就已无脾。血小板减少症的成功治疗与潜在淋巴瘤的有效控制相关。脾切除术在10例病例中的9例(90%)取得了良好效果,并在5例患者中发现了隐匿性淋巴瘤。化疗药物在12次试验中的7次(58%)取得了成功,且仅在潜在疾病也得到控制时才有效。总体预后与淋巴瘤的状况相关,特发性血小板减少性紫癜的发生并未改变这一情况。